Ferrous Sulfate Iron Supplement Drops Recalled for Manufacturing Stability Issues
All lots of Ferrous Sulfate Iron Supplement Drops are being recalled nationwide. The manufacturer went out of business and cannot complete required stability studies to verify product safety.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a precautionary recall due to incomplete manufacturing stability studies caused by firm closure. While FDA classified this as Class II, no illnesses or injuries have been reported, and the hazard remains theoretical pending completion of safety verification studies.
Plain-English summary
Ferrous Sulfate Iron Supplement Drops, packaged in 50 mL bottles and distributed nationwide in the USA and Puerto Rico, are being recalled. The product is manufactured by Akorn, Inc., and all lots are affected.
The recall was issued because the manufacturer went out of business and can no longer continue the stability studies required by FDA regulations. These studies are essential to verify that the product maintains its quality and potency throughout its shelf life.
Consumers who have purchased this product should stop using it and consult with a healthcare provider or pharmacist about alternative iron supplements. Those with questions about the recall should contact the FDA or a healthcare professional.
The recalled product
- Product
- Ferrous Sulfate Iron Supplement Drops, packaged in 50 mL bottles, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Supplement / Iron
- Hazard
- stability-unverified
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27